Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Headlines
CSCO 2026 Debate | Professors Wenyan Chen and Tengfei Chao: Should Immunotherapy Be Combined with Chemotherapy or an ADC in First-Line Treatment of Advanced TNBC?
2026.10.21
CSCO 2026 | Professor Hong Bu: Standardizing Breast Pathology Diagnosis Requires “Knowing, Understanding, and Applying the Standards,” While Digital and Intelligent Transformation Must Address Clinical Pain Points
2026.10.21
CSCO 2026 | Professor Chunfang Hao: ADCs Are Expanding Across the Breast Cancer Treatment Continuum, Advancing From Later Lines to First-Line Therapy and From Monotherapy to Combination Regimens
2026.10.21
CSCO 2026 | Professor Yanxia Shi: Early Intervention Guided by ctDNA and Dual-Target ADC Innovation Are Reshaping Precision Breast Cancer Treatment
2026.10.21
CSCO 2026 | Professor Yongmei Yin: OptiTROP-Breast05 Wins the “2026 Innovation Research Award,” as China’s First Homegrown TROP2 ADC Advances First-Line TNBC Treatment
2026.10.21
Blood × Immunology: Six Leading Chinese and French Experts Discuss Frontiers, Breakthroughs, and Clinical Translation | 2026 China-France Scientific Symposium on Hematology and Immunology
2026.10.21
Professor Lei Wang: Applications of Holographic Imaging in Partial  Nephrectomy
2026.10.19
A New Chapter of Innovation: Fudan University Shanghai Cancer Center Officially Establishes Its Urologic Oncology Center
2026.10.19
Professor Lei Wang: Applications of Holographic Imaging in Partial Nephrectomy 
2026.10.19
Professor Aili Zhang: Rapid Testosterone Suppression, Stable Inhibition, and Long-Term Management—Reassessing the Role of LHRH Antagonists in Prostate Cancer ADT
2026.10.19
Posted inIOncology

CSCO 2026 Debate | Professors Wenyan Chen and Tengfei Chao: Should Immunotherapy Be Combined with Chemotherapy or an ADC in First-Line Treatment of Advanced TNBC?

Posted by By Peng Geng 2026.10.21
Continue Reading
Posted inIOncology

CSCO 2026 | Professor Hong Bu: Standardizing Breast Pathology Diagnosis Requires “Knowing, Understanding, and Applying the Standards,” While Digital and Intelligent Transformation Must Address Clinical Pain Points

Posted by By Peng Longmei 2026.10.21
Continue Reading

How Do Banks Use Automation: Benefits, Challenges, & Solutions in 2024

Posted by By Mourabit Halima 2023.08.18
Top 10 Use Cases & Examples of RPA in Banking Industry 2022 The increase in financial regulatory standards over the last few years posed a big issue for financial businesses.…
Read More

Posts pagination

Previous page 1 … 20
Recent Posts
  • CSCO 2026 Debate | Professors Wenyan Chen and Tengfei Chao: Should Immunotherapy Be Combined with Chemotherapy or an ADC in First-Line Treatment of Advanced TNBC?
  • CSCO 2026 | Professor Hong Bu: Standardizing Breast Pathology Diagnosis Requires “Knowing, Understanding, and Applying the Standards,” While Digital and Intelligent Transformation Must Address Clinical Pain Points
  • CSCO 2026 | Professor Chunfang Hao: ADCs Are Expanding Across the Breast Cancer Treatment Continuum, Advancing From Later Lines to First-Line Therapy and From Monotherapy to Combination Regimens
  • CSCO 2026 | Professor Yanxia Shi: Early Intervention Guided by ctDNA and Dual-Target ADC Innovation Are Reshaping Precision Breast Cancer Treatment
  • CSCO 2026 | Professor Yongmei Yin: OptiTROP-Breast05 Wins the “2026 Innovation Research Award,” as China’s First Homegrown TROP2 ADC Advances First-Line TNBC Treatment
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    Post You Might Like
    Posted inIOncology
    CSCO 2026 Debate | Professors Wenyan Chen and Tengfei Chao: Should Immunotherapy Be Combined with Chemotherapy or an ADC in First-Line Treatment of Advanced TNBC?
    Posted by By Peng Geng 2026.10.21
    Posted inIOncology
    CSCO 2026 | Professor Hong Bu: Standardizing Breast Pathology Diagnosis Requires “Knowing, Understanding, and Applying the Standards,” While Digital and Intelligent Transformation Must Address Clinical Pain Points
    Posted by By Peng Longmei 2026.10.21
    Posted inIOncology
    CSCO 2026 | Professor Chunfang Hao: ADCs Are Expanding Across the Breast Cancer Treatment Continuum, Advancing From Later Lines to First-Line Therapy and From Monotherapy to Combination Regimens
    Posted by By Ailiyaer Ainiwaer（Elyar Anwar） 2026.10.21
    Posted inIOncology
    CSCO 2026 | Professor Yanxia Shi: Early Intervention Guided by ctDNA and Dual-Target ADC Innovation Are Reshaping Precision Breast Cancer Treatment
    Posted by By Peter W. PENG 2026.10.21
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top

    Welcome to Mediamedic 👋
    It’s nice to meet you.

    Dive into a world of trusted health insights. Subscribe for monthly updates straight to your inbox

    Privacy is part of our care. No spam, just wellness.

    🔒 Privacy policy

    Check your inbox or spam folder to confirm your subscription.

    • Facebook
    • X (Twitter)
    • LinkedIn
    • More Networks
    Share via
    Facebook
    X (Twitter)
    LinkedIn
    Mix
    Email
    Print
    Copy Link
    Copy link
    CopyCopied